Claims
- 1. A preparation comprising a peptide selected from teh group consisting of ESCDKHYWD (SEQ ID NO:2), RFRYCAPPG (SEQ ID NO:3), LLRCNDTNYSGF (SEQ ID NO: 4), STWFGFNGTRAENRYIYWH (SEQ ID NO:5), DNRTIISLN (SEQ ID NO:6), NELDRFGLAESLLE (SEQ ID NO: 7), PLVPTGSENLKSL (SEQ ID NO: 8), PLSPRTLNAWVKL (SEQ ID NO: 9) EEKKFGAEVVPGFQALSEGCTPYEINQMLNCV (SEQ ID NO: 10), GLQKCVRMYNPTNILD (SEQ ID NO:11), FQSYVDRFYKSLRAEQTD (SEQ ID NO: 12), QNANPDCKLVLKGL (SEQ ID NO: 13), NPTLEEMLTACQG (SEQ ID NO: 14), GGPGQKARLMAEALKE (SEQ ID NO: 15), ARQCRAPRRQGCWKCGK (SEQ ID NO: 16), fragments thereof having a length of up to 7 amino acids, and mixtures thereof.
- 2. A method of detecting HIV or SIV comprising admixing the preparaton of claim 1 with a sample for differential diagnosis.
- 3. The method of claim 2, wherein diagnosis is by protein assay or PCR assay.
- 4. A peptide preparation comprising a peptide selected from the group consisting of ESCDKHYWD (SEQ ID NO: 2), RFRYCAPPG (SEQ ID NO: 3), LLRCNDTNYSGF (SEQ ID NO: 4), STWFGFNGTRAENRYIYWH (SEQ ID NO: 5), DNRTIISLN (SEQ ID NO: 6), NELDRFGLAESLLE (SEQ ID NO: 7), PLVPTGSENLKSL (SEQ ID NO: 8), PLSPRTLNAWVKL (SEQ ID NO: 9), EEKKFGAEVVPGFQALSEGCTPYEINQMLNCV (SEQ ID NO: 10), GLQKCVRMYNPTNILD (SEQ ID NO: 11), FQSYVDRFYKSLRAEQTD (SEQ ID NO: 12), QNANPDCKLVLKGL (SEQ ID NO: 13), NPTLEEMLTACQG (SEQ ID NO: 14), GGPGQKARLMAEALKE (SEQ ID NO: 15), ARQCRAPRRQGCWKCGK (SEQ ID NO: 16), and mixtures thereof.
- 5. A preparation according to claim 4, which further comprises from HIV-2.sub.D205 amino acid sequence 2-11 of rev, amino acid sequence 186-200 of vif, amino acid sequence 2-33 of env, amino acid sequence 118-204 of env, or a mixture thereof.
- 6. A peptide selected from the group consisting of ESCDKHYWD (SEQ ID NO:2), RFRYCAPPG (SEQ ID NO: 3), LLRCNDTNYSGF (SEQ ID NO: 4), STWFGFNGTRAENRYIYWH (SEQ ID NO: 5), DNRTIISLN (SEQ ID NO: 6), NELDRFGLAESLLE (SEQ ID NO: 7), PLVPTGSENLKSL (SEQ ID NO: 8), PLSPRTLNAWVKL (SEQ ID NO: 9), EEKKFGAEVVPGFQALSEGCTPYEINQMLNCV (SEQ ID NO: 10), GLQKCVRMYNPTNILD (SEQ ID NO: 11), FQSYVDRFYKSLRAEQTD (SEQ ID NO: 12), QNANPDCKLVLKGL (SEQ ID NO: 13), NPTLEEMLTACQG (SEQ ID NO: 14), GGPGQKARLMAEALKE (SEQ ID NO: 15), ARQCRAPRRQGCWKCGK (SEQ ID NO: 16), or a fragment, thereof, having a length of up to 7 amino acids, and mixtures thereof.
- 7. The peptide of claim 6 that is, ESCDKHYWD (SEQ ID NO: 2).
- 8. The peptide of claim 6 that is RFRYCAPPG (SEQ ID NO: 3).
- 9. The peptide of claim 6 that is LLRCNDTNYSGF (SEQ ID NO: 4).
- 10. The peptide of claim 6 that is STWFGFNGTRAENRYIYWH (SEQ ID NO: 5).
- 11. The peptide of claim 6 that is DNRTIISLN (SEQ ID NO: 6).
- 12. The peptide of claim 6 that is NELDRFGLAESLLE (SEQ ID NO: 7).
- 13. The peptide of claim 6 that is PLVPTGSENLKSL (SEQ ID NO: 8).
- 14. The peptide of claim 6 that is PLSPRTLNAWVKL (SEQ ID NO: 9).
- 15. The peptide of claim 6 that is EEKKFGAEVVPGFQALSEGCTPYEINQ-MLNCV (SEQ ID NO: 10).
- 16. The peptide of claim 6 that is GLQKCVRMYNPTNILD (SEQ ID NO: 11).
- 17. The peptide of claim 6 that is FQSYVDRFYKSLRAEQTD (SEQ ID NO: 12).
- 18. The peptide of claim 6 that is QNANPDCKLVLKGL (SEQ ID NO: 13).
- 19. A method of using the peptide of claim 6 for producing antibodies to HIV-2.sub.D205 in vitro.
Priority Claims (1)
Number |
Date |
Country |
Kind |
39 34 366.9 |
Oct 1989 |
DEX |
|
Parent Case Info
This application is a continuation of application Ser. No. 08/780,132, filed Dec. 26, 1996, now abandoned, which is a continuation of application Ser. No. 08/205,761, filed Mar. 4, 1994, now abandoned, which is a continuation of application Serial No. 07/868,351, filed Apr 13, 1992, now abandoned, which is a 371 of PCT/EP90/01729, filed Oct. 12, 1990.
Foreign Referenced Citations (2)
Number |
Date |
Country |
0283327 |
Sep 1988 |
EPX |
0347365 |
Dec 1989 |
EPX |
Continuations (3)
|
Number |
Date |
Country |
Parent |
780132 |
Dec 1996 |
|
Parent |
205761 |
Mar 1994 |
|
Parent |
868351 |
Apr 1992 |
|